1. Home
  2. OPTN vs IDN Comparison

OPTN vs IDN Comparison

Compare OPTN & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • IDN
  • Stock Information
  • Founded
  • OPTN 2010
  • IDN 1994
  • Country
  • OPTN United States
  • IDN United States
  • Employees
  • OPTN N/A
  • IDN N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • IDN Computer Software: Prepackaged Software
  • Sector
  • OPTN Health Care
  • IDN Technology
  • Exchange
  • OPTN Nasdaq
  • IDN Nasdaq
  • Market Cap
  • OPTN 55.4M
  • IDN 50.8M
  • IPO Year
  • OPTN 2017
  • IDN 1999
  • Fundamental
  • Price
  • OPTN $5.77
  • IDN $2.65
  • Analyst Decision
  • OPTN Strong Buy
  • IDN Buy
  • Analyst Count
  • OPTN 3
  • IDN 3
  • Target Price
  • OPTN $16.67
  • IDN $3.33
  • AVG Volume (30 Days)
  • OPTN 18.9K
  • IDN 59.1K
  • Earning Date
  • OPTN 03-06-2025
  • IDN 03-20-2025
  • Dividend Yield
  • OPTN N/A
  • IDN N/A
  • EPS Growth
  • OPTN N/A
  • IDN N/A
  • EPS
  • OPTN N/A
  • IDN N/A
  • Revenue
  • OPTN $75,672,000.00
  • IDN $19,236,000.00
  • Revenue This Year
  • OPTN $13.42
  • IDN $2.09
  • Revenue Next Year
  • OPTN $38.54
  • IDN $8.67
  • P/E Ratio
  • OPTN N/A
  • IDN N/A
  • Revenue Growth
  • OPTN 5.13
  • IDN 5.22
  • 52 Week Low
  • OPTN $4.82
  • IDN $1.67
  • 52 Week High
  • OPTN $31.50
  • IDN $4.46
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 44.78
  • IDN 48.32
  • Support Level
  • OPTN $5.20
  • IDN $2.51
  • Resistance Level
  • OPTN $6.49
  • IDN $2.70
  • Average True Range (ATR)
  • OPTN 0.50
  • IDN 0.16
  • MACD
  • OPTN 0.04
  • IDN -0.01
  • Stochastic Oscillator
  • OPTN 44.19
  • IDN 36.84

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.

Share on Social Networks: